German researchers resolved a longstanding question regarding the sex disparity in susceptibility to acute kidney injury (AKI). Their study demonstrated that estrogen exerts a protective effect in females by inhibiting ferroptosis, a form of programmed cell death in renal tubules. This molecular insight opens avenues for developing estrogen-based therapies to reduce AKI risk in males and postmenopausal females, potentially improving clinical outcomes in this critical condition.